Ahay I am very encouraged by this announcement despite the poor market response. I am very hopeful of a trail starting as quickly as possible.
I am not sure what the trial will involve and how long it will take to run, but I invite speculation. Is it as challenging and as long as a cancer treatment trial, or could this advance more quickly from Phase 1 to 2 and then 3?
I assume safety is likely to be low risk, and QOL and blood work can reveal efficacy relatively quickly …. Am I being naive?
Thanks QQ
Ann: GMP Manufacturing Process Developed for IMP761 LAG-3 Agonist, page-6
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.5¢ |
Change
-0.020(5.80%) |
Mkt cap ! $479.3M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.0¢ | 32.5¢ | $716.0K | 2.150M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 41 | 214212 | 32.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 155283 | 27 |
View Market Depth
| Last trade - 14.38pm 27/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |